Global Diarrhea Vaccine Market Growth 2026-2032
The global Diarrhea Vaccine market size is predicted to grow from US$ 1150 million in 2025 to US$ 1372 million in 2032; it is expected to grow at a CAGR of 2.6% from 2026 to 2032.
Diarrhea vaccines generally refer to vaccines used to prevent infectious diarrhea caused by specific pathogens (such as rotavirus, norovirus, etc.). There are many types of diarrhea vaccines, mainly including EV71 vaccines, rotavirus vaccines, and cholera vaccines. The global market size is currently over $1.2 billion, with the Chinese market exceeding $400 million.
United States market for Diarrhea Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Diarrhea Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Diarrhea Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Diarrhea Vaccine players cover MSD, Sanofi, EuBiologics, Vabiotech, PaxVax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Diarrhea Vaccine Industry Forecast? looks at past sales and reviews total world Diarrhea Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Diarrhea Vaccine sales for 2026 through 2032. With Diarrhea Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diarrhea Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Diarrhea Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diarrhea Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Diarrhea Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diarrhea Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diarrhea Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Diarrhea Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Diarrhea Vaccine market?
What factors are driving Diarrhea Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diarrhea Vaccine market opportunities vary by end market size?
How does Diarrhea Vaccine break out by Type, by Application?
Diarrhea vaccines generally refer to vaccines used to prevent infectious diarrhea caused by specific pathogens (such as rotavirus, norovirus, etc.). There are many types of diarrhea vaccines, mainly including EV71 vaccines, rotavirus vaccines, and cholera vaccines. The global market size is currently over $1.2 billion, with the Chinese market exceeding $400 million.
United States market for Diarrhea Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Diarrhea Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Diarrhea Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Diarrhea Vaccine players cover MSD, Sanofi, EuBiologics, Vabiotech, PaxVax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Diarrhea Vaccine Industry Forecast? looks at past sales and reviews total world Diarrhea Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Diarrhea Vaccine sales for 2026 through 2032. With Diarrhea Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diarrhea Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Diarrhea Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diarrhea Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Diarrhea Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diarrhea Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diarrhea Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Diarrhea Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Rotavirus Vaccine
- Cholera Vaccine
- EV71 Vaccine
- Newborn
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MSD
- Sanofi
- EuBiologics
- Vabiotech
- PaxVax
- GlaxoSmithKline
- Serum Institute of India
- Bharat Biotech
- Chinese Academy of Medical Sciences
- Sinovac Biotech Ltd
- China National Biotec Corporation
- Shanghai United Cell Biotechnology
What is the 10-year outlook for the global Diarrhea Vaccine market?
What factors are driving Diarrhea Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diarrhea Vaccine market opportunities vary by end market size?
How does Diarrhea Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diarrhea Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Diarrhea Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Diarrhea Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Diarrhea Vaccine Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 EV71 Vaccine
2.2.4 Diarrhea Vaccine Sales by Type
2.2.4.1 Global Diarrhea Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Diarrhea Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Diarrhea Vaccine Sale Price by Type (2021-2026)
2.3 Diarrhea Vaccine Segment by Application
2.3.1 Newborn
2.3.2 Adult
2.3.3 Diarrhea Vaccine Sales by Application
2.3.3.1 Global Diarrhea Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Diarrhea Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Diarrhea Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Diarrhea Vaccine Breakdown Data by Company
3.1.1 Global Diarrhea Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Diarrhea Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Diarrhea Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Diarrhea Vaccine Revenue by Company (2021-2026)
3.2.2 Global Diarrhea Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Diarrhea Vaccine Sale Price by Company
3.4 Key Manufacturers Diarrhea Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diarrhea Vaccine Product Location Distribution
3.4.2 Players Diarrhea Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DIARRHEA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Diarrhea Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Diarrhea Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Diarrhea Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Diarrhea Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Diarrhea Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Diarrhea Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Diarrhea Vaccine Sales Growth
4.4 APAC Diarrhea Vaccine Sales Growth
4.5 Europe Diarrhea Vaccine Sales Growth
4.6 Middle East & Africa Diarrhea Vaccine Sales Growth
5 AMERICAS
5.1 Americas Diarrhea Vaccine Sales by Country
5.1.1 Americas Diarrhea Vaccine Sales by Country (2021-2026)
5.1.2 Americas Diarrhea Vaccine Revenue by Country (2021-2026)
5.2 Americas Diarrhea Vaccine Sales by Type (2021-2026)
5.3 Americas Diarrhea Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diarrhea Vaccine Sales by Region
6.1.1 APAC Diarrhea Vaccine Sales by Region (2021-2026)
6.1.2 APAC Diarrhea Vaccine Revenue by Region (2021-2026)
6.2 APAC Diarrhea Vaccine Sales by Type (2021-2026)
6.3 APAC Diarrhea Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Diarrhea Vaccine by Country
7.1.1 Europe Diarrhea Vaccine Sales by Country (2021-2026)
7.1.2 Europe Diarrhea Vaccine Revenue by Country (2021-2026)
7.2 Europe Diarrhea Vaccine Sales by Type (2021-2026)
7.3 Europe Diarrhea Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diarrhea Vaccine by Country
8.1.1 Middle East & Africa Diarrhea Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Diarrhea Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Diarrhea Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Diarrhea Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diarrhea Vaccine
10.3 Manufacturing Process Analysis of Diarrhea Vaccine
10.4 Industry Chain Structure of Diarrhea Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diarrhea Vaccine Distributors
11.3 Diarrhea Vaccine Customer
12 WORLD FORECAST REVIEW FOR DIARRHEA VACCINE BY GEOGRAPHIC REGION
12.1 Global Diarrhea Vaccine Market Size Forecast by Region
12.1.1 Global Diarrhea Vaccine Forecast by Region (2027-2032)
12.1.2 Global Diarrhea Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Diarrhea Vaccine Forecast by Type (2027-2032)
12.7 Global Diarrhea Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD Diarrhea Vaccine Product Portfolios and Specifications
13.1.3 MSD Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Diarrhea Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 EuBiologics
13.3.1 EuBiologics Company Information
13.3.2 EuBiologics Diarrhea Vaccine Product Portfolios and Specifications
13.3.3 EuBiologics Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 EuBiologics Main Business Overview
13.3.5 EuBiologics Latest Developments
13.4 Vabiotech
13.4.1 Vabiotech Company Information
13.4.2 Vabiotech Diarrhea Vaccine Product Portfolios and Specifications
13.4.3 Vabiotech Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Vabiotech Main Business Overview
13.4.5 Vabiotech Latest Developments
13.5 PaxVax
13.5.1 PaxVax Company Information
13.5.2 PaxVax Diarrhea Vaccine Product Portfolios and Specifications
13.5.3 PaxVax Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 PaxVax Main Business Overview
13.5.5 PaxVax Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Diarrhea Vaccine Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Serum Institute of India
13.7.1 Serum Institute of India Company Information
13.7.2 Serum Institute of India Diarrhea Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute of India Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Serum Institute of India Main Business Overview
13.7.5 Serum Institute of India Latest Developments
13.8 Bharat Biotech
13.8.1 Bharat Biotech Company Information
13.8.2 Bharat Biotech Diarrhea Vaccine Product Portfolios and Specifications
13.8.3 Bharat Biotech Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bharat Biotech Main Business Overview
13.8.5 Bharat Biotech Latest Developments
13.9 Chinese Academy of Medical Sciences
13.9.1 Chinese Academy of Medical Sciences Company Information
13.9.2 Chinese Academy of Medical Sciences Diarrhea Vaccine Product Portfolios and Specifications
13.9.3 Chinese Academy of Medical Sciences Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Chinese Academy of Medical Sciences Main Business Overview
13.9.5 Chinese Academy of Medical Sciences Latest Developments
13.10 Sinovac Biotech Ltd
13.10.1 Sinovac Biotech Ltd Company Information
13.10.2 Sinovac Biotech Ltd Diarrhea Vaccine Product Portfolios and Specifications
13.10.3 Sinovac Biotech Ltd Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sinovac Biotech Ltd Main Business Overview
13.10.5 Sinovac Biotech Ltd Latest Developments
13.11 China National Biotec Corporation
13.11.1 China National Biotec Corporation Company Information
13.11.2 China National Biotec Corporation Diarrhea Vaccine Product Portfolios and Specifications
13.11.3 China National Biotec Corporation Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 China National Biotec Corporation Main Business Overview
13.11.5 China National Biotec Corporation Latest Developments
13.12 Shanghai United Cell Biotechnology
13.12.1 Shanghai United Cell Biotechnology Company Information
13.12.2 Shanghai United Cell Biotechnology Diarrhea Vaccine Product Portfolios and Specifications
13.12.3 Shanghai United Cell Biotechnology Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai United Cell Biotechnology Main Business Overview
13.12.5 Shanghai United Cell Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diarrhea Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Diarrhea Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Diarrhea Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Diarrhea Vaccine Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 EV71 Vaccine
2.2.4 Diarrhea Vaccine Sales by Type
2.2.4.1 Global Diarrhea Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Diarrhea Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Diarrhea Vaccine Sale Price by Type (2021-2026)
2.3 Diarrhea Vaccine Segment by Application
2.3.1 Newborn
2.3.2 Adult
2.3.3 Diarrhea Vaccine Sales by Application
2.3.3.1 Global Diarrhea Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Diarrhea Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Diarrhea Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Diarrhea Vaccine Breakdown Data by Company
3.1.1 Global Diarrhea Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Diarrhea Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Diarrhea Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Diarrhea Vaccine Revenue by Company (2021-2026)
3.2.2 Global Diarrhea Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Diarrhea Vaccine Sale Price by Company
3.4 Key Manufacturers Diarrhea Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diarrhea Vaccine Product Location Distribution
3.4.2 Players Diarrhea Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DIARRHEA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Diarrhea Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Diarrhea Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Diarrhea Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Diarrhea Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Diarrhea Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Diarrhea Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Diarrhea Vaccine Sales Growth
4.4 APAC Diarrhea Vaccine Sales Growth
4.5 Europe Diarrhea Vaccine Sales Growth
4.6 Middle East & Africa Diarrhea Vaccine Sales Growth
5 AMERICAS
5.1 Americas Diarrhea Vaccine Sales by Country
5.1.1 Americas Diarrhea Vaccine Sales by Country (2021-2026)
5.1.2 Americas Diarrhea Vaccine Revenue by Country (2021-2026)
5.2 Americas Diarrhea Vaccine Sales by Type (2021-2026)
5.3 Americas Diarrhea Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diarrhea Vaccine Sales by Region
6.1.1 APAC Diarrhea Vaccine Sales by Region (2021-2026)
6.1.2 APAC Diarrhea Vaccine Revenue by Region (2021-2026)
6.2 APAC Diarrhea Vaccine Sales by Type (2021-2026)
6.3 APAC Diarrhea Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Diarrhea Vaccine by Country
7.1.1 Europe Diarrhea Vaccine Sales by Country (2021-2026)
7.1.2 Europe Diarrhea Vaccine Revenue by Country (2021-2026)
7.2 Europe Diarrhea Vaccine Sales by Type (2021-2026)
7.3 Europe Diarrhea Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diarrhea Vaccine by Country
8.1.1 Middle East & Africa Diarrhea Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Diarrhea Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Diarrhea Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Diarrhea Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diarrhea Vaccine
10.3 Manufacturing Process Analysis of Diarrhea Vaccine
10.4 Industry Chain Structure of Diarrhea Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diarrhea Vaccine Distributors
11.3 Diarrhea Vaccine Customer
12 WORLD FORECAST REVIEW FOR DIARRHEA VACCINE BY GEOGRAPHIC REGION
12.1 Global Diarrhea Vaccine Market Size Forecast by Region
12.1.1 Global Diarrhea Vaccine Forecast by Region (2027-2032)
12.1.2 Global Diarrhea Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Diarrhea Vaccine Forecast by Type (2027-2032)
12.7 Global Diarrhea Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD Diarrhea Vaccine Product Portfolios and Specifications
13.1.3 MSD Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Diarrhea Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 EuBiologics
13.3.1 EuBiologics Company Information
13.3.2 EuBiologics Diarrhea Vaccine Product Portfolios and Specifications
13.3.3 EuBiologics Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 EuBiologics Main Business Overview
13.3.5 EuBiologics Latest Developments
13.4 Vabiotech
13.4.1 Vabiotech Company Information
13.4.2 Vabiotech Diarrhea Vaccine Product Portfolios and Specifications
13.4.3 Vabiotech Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Vabiotech Main Business Overview
13.4.5 Vabiotech Latest Developments
13.5 PaxVax
13.5.1 PaxVax Company Information
13.5.2 PaxVax Diarrhea Vaccine Product Portfolios and Specifications
13.5.3 PaxVax Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 PaxVax Main Business Overview
13.5.5 PaxVax Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Diarrhea Vaccine Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 Serum Institute of India
13.7.1 Serum Institute of India Company Information
13.7.2 Serum Institute of India Diarrhea Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute of India Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Serum Institute of India Main Business Overview
13.7.5 Serum Institute of India Latest Developments
13.8 Bharat Biotech
13.8.1 Bharat Biotech Company Information
13.8.2 Bharat Biotech Diarrhea Vaccine Product Portfolios and Specifications
13.8.3 Bharat Biotech Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bharat Biotech Main Business Overview
13.8.5 Bharat Biotech Latest Developments
13.9 Chinese Academy of Medical Sciences
13.9.1 Chinese Academy of Medical Sciences Company Information
13.9.2 Chinese Academy of Medical Sciences Diarrhea Vaccine Product Portfolios and Specifications
13.9.3 Chinese Academy of Medical Sciences Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Chinese Academy of Medical Sciences Main Business Overview
13.9.5 Chinese Academy of Medical Sciences Latest Developments
13.10 Sinovac Biotech Ltd
13.10.1 Sinovac Biotech Ltd Company Information
13.10.2 Sinovac Biotech Ltd Diarrhea Vaccine Product Portfolios and Specifications
13.10.3 Sinovac Biotech Ltd Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sinovac Biotech Ltd Main Business Overview
13.10.5 Sinovac Biotech Ltd Latest Developments
13.11 China National Biotec Corporation
13.11.1 China National Biotec Corporation Company Information
13.11.2 China National Biotec Corporation Diarrhea Vaccine Product Portfolios and Specifications
13.11.3 China National Biotec Corporation Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 China National Biotec Corporation Main Business Overview
13.11.5 China National Biotec Corporation Latest Developments
13.12 Shanghai United Cell Biotechnology
13.12.1 Shanghai United Cell Biotechnology Company Information
13.12.2 Shanghai United Cell Biotechnology Diarrhea Vaccine Product Portfolios and Specifications
13.12.3 Shanghai United Cell Biotechnology Diarrhea Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai United Cell Biotechnology Main Business Overview
13.12.5 Shanghai United Cell Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Diarrhea Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Diarrhea Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of EV71 Vaccine
Table 6. Global Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 7. Global Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Diarrhea Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Diarrhea Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Diarrhea Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Global Diarrhea Vaccine Sale by Application (2021-2026) & (K Dose)
Table 12. Global Diarrhea Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Diarrhea Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Diarrhea Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Diarrhea Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 16. Global Diarrhea Vaccine Sales by Company (2021-2026) & (K Dose)
Table 17. Global Diarrhea Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Diarrhea Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Diarrhea Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Diarrhea Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 21. Key Manufacturers Diarrhea Vaccine Producing Area Distribution and Sales Area
Table 22. Players Diarrhea Vaccine Products Offered
Table 23. Diarrhea Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Diarrhea Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 27. Global Diarrhea Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Diarrhea Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Diarrhea Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Diarrhea Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 31. Global Diarrhea Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Diarrhea Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Diarrhea Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Diarrhea Vaccine Sales by Country (2021-2026) & (K Dose)
Table 35. Americas Diarrhea Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Diarrhea Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 38. Americas Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 39. APAC Diarrhea Vaccine Sales by Region (2021-2026) & (K Dose)
Table 40. APAC Diarrhea Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Diarrhea Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 43. APAC Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 44. Europe Diarrhea Vaccine Sales by Country (2021-2026) & (K Dose)
Table 45. Europe Diarrhea Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 47. Europe Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 48. Middle East & Africa Diarrhea Vaccine Sales by Country (2021-2026) & (K Dose)
Table 49. Middle East & Africa Diarrhea Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 51. Middle East & Africa Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Diarrhea Vaccine
Table 53. Key Market Challenges & Risks of Diarrhea Vaccine
Table 54. Key Industry Trends of Diarrhea Vaccine
Table 55. Diarrhea Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Diarrhea Vaccine Distributors List
Table 58. Diarrhea Vaccine Customer List
Table 59. Global Diarrhea Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 60. Global Diarrhea Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Diarrhea Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 62. Americas Diarrhea Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Diarrhea Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 64. APAC Diarrhea Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Diarrhea Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 66. Europe Diarrhea Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Diarrhea Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 68. Middle East & Africa Diarrhea Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Diarrhea Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 70. Global Diarrhea Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Diarrhea Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 72. Global Diarrhea Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. MSD Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. MSD Diarrhea Vaccine Product Portfolios and Specifications
Table 75. MSD Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 76. MSD Main Business
Table 77. MSD Latest Developments
Table 78. Sanofi Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Diarrhea Vaccine Product Portfolios and Specifications
Table 80. Sanofi Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. EuBiologics Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. EuBiologics Diarrhea Vaccine Product Portfolios and Specifications
Table 85. EuBiologics Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 86. EuBiologics Main Business
Table 87. EuBiologics Latest Developments
Table 88. Vabiotech Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Vabiotech Diarrhea Vaccine Product Portfolios and Specifications
Table 90. Vabiotech Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Vabiotech Main Business
Table 92. Vabiotech Latest Developments
Table 93. PaxVax Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. PaxVax Diarrhea Vaccine Product Portfolios and Specifications
Table 95. PaxVax Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. PaxVax Main Business
Table 97. PaxVax Latest Developments
Table 98. GlaxoSmithKline Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Diarrhea Vaccine Product Portfolios and Specifications
Table 100. GlaxoSmithKline Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. Serum Institute of India Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Serum Institute of India Diarrhea Vaccine Product Portfolios and Specifications
Table 105. Serum Institute of India Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 106. Serum Institute of India Main Business
Table 107. Serum Institute of India Latest Developments
Table 108. Bharat Biotech Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bharat Biotech Diarrhea Vaccine Product Portfolios and Specifications
Table 110. Bharat Biotech Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 111. Bharat Biotech Main Business
Table 112. Bharat Biotech Latest Developments
Table 113. Chinese Academy of Medical Sciences Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Chinese Academy of Medical Sciences Diarrhea Vaccine Product Portfolios and Specifications
Table 115. Chinese Academy of Medical Sciences Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 116. Chinese Academy of Medical Sciences Main Business
Table 117. Chinese Academy of Medical Sciences Latest Developments
Table 118. Sinovac Biotech Ltd Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinovac Biotech Ltd Diarrhea Vaccine Product Portfolios and Specifications
Table 120. Sinovac Biotech Ltd Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 121. Sinovac Biotech Ltd Main Business
Table 122. Sinovac Biotech Ltd Latest Developments
Table 123. China National Biotec Corporation Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. China National Biotec Corporation Diarrhea Vaccine Product Portfolios and Specifications
Table 125. China National Biotec Corporation Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 126. China National Biotec Corporation Main Business
Table 127. China National Biotec Corporation Latest Developments
Table 128. Shanghai United Cell Biotechnology Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai United Cell Biotechnology Diarrhea Vaccine Product Portfolios and Specifications
Table 130. Shanghai United Cell Biotechnology Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 131. Shanghai United Cell Biotechnology Main Business
Table 132. Shanghai United Cell Biotechnology Latest Developments
Table 1. Diarrhea Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Diarrhea Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of EV71 Vaccine
Table 6. Global Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 7. Global Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Diarrhea Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Diarrhea Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Diarrhea Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Global Diarrhea Vaccine Sale by Application (2021-2026) & (K Dose)
Table 12. Global Diarrhea Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Diarrhea Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Diarrhea Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Diarrhea Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 16. Global Diarrhea Vaccine Sales by Company (2021-2026) & (K Dose)
Table 17. Global Diarrhea Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Diarrhea Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Diarrhea Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Diarrhea Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 21. Key Manufacturers Diarrhea Vaccine Producing Area Distribution and Sales Area
Table 22. Players Diarrhea Vaccine Products Offered
Table 23. Diarrhea Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Diarrhea Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 27. Global Diarrhea Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Diarrhea Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Diarrhea Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Diarrhea Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 31. Global Diarrhea Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Diarrhea Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Diarrhea Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Diarrhea Vaccine Sales by Country (2021-2026) & (K Dose)
Table 35. Americas Diarrhea Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Diarrhea Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 38. Americas Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 39. APAC Diarrhea Vaccine Sales by Region (2021-2026) & (K Dose)
Table 40. APAC Diarrhea Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Diarrhea Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 43. APAC Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 44. Europe Diarrhea Vaccine Sales by Country (2021-2026) & (K Dose)
Table 45. Europe Diarrhea Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 47. Europe Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 48. Middle East & Africa Diarrhea Vaccine Sales by Country (2021-2026) & (K Dose)
Table 49. Middle East & Africa Diarrhea Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Diarrhea Vaccine Sales by Type (2021-2026) & (K Dose)
Table 51. Middle East & Africa Diarrhea Vaccine Sales by Application (2021-2026) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Diarrhea Vaccine
Table 53. Key Market Challenges & Risks of Diarrhea Vaccine
Table 54. Key Industry Trends of Diarrhea Vaccine
Table 55. Diarrhea Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Diarrhea Vaccine Distributors List
Table 58. Diarrhea Vaccine Customer List
Table 59. Global Diarrhea Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 60. Global Diarrhea Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Diarrhea Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 62. Americas Diarrhea Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Diarrhea Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 64. APAC Diarrhea Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Diarrhea Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 66. Europe Diarrhea Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Diarrhea Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 68. Middle East & Africa Diarrhea Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Diarrhea Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 70. Global Diarrhea Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Diarrhea Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 72. Global Diarrhea Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. MSD Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. MSD Diarrhea Vaccine Product Portfolios and Specifications
Table 75. MSD Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 76. MSD Main Business
Table 77. MSD Latest Developments
Table 78. Sanofi Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Diarrhea Vaccine Product Portfolios and Specifications
Table 80. Sanofi Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. EuBiologics Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. EuBiologics Diarrhea Vaccine Product Portfolios and Specifications
Table 85. EuBiologics Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 86. EuBiologics Main Business
Table 87. EuBiologics Latest Developments
Table 88. Vabiotech Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Vabiotech Diarrhea Vaccine Product Portfolios and Specifications
Table 90. Vabiotech Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Vabiotech Main Business
Table 92. Vabiotech Latest Developments
Table 93. PaxVax Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. PaxVax Diarrhea Vaccine Product Portfolios and Specifications
Table 95. PaxVax Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. PaxVax Main Business
Table 97. PaxVax Latest Developments
Table 98. GlaxoSmithKline Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Diarrhea Vaccine Product Portfolios and Specifications
Table 100. GlaxoSmithKline Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. Serum Institute of India Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Serum Institute of India Diarrhea Vaccine Product Portfolios and Specifications
Table 105. Serum Institute of India Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 106. Serum Institute of India Main Business
Table 107. Serum Institute of India Latest Developments
Table 108. Bharat Biotech Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bharat Biotech Diarrhea Vaccine Product Portfolios and Specifications
Table 110. Bharat Biotech Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 111. Bharat Biotech Main Business
Table 112. Bharat Biotech Latest Developments
Table 113. Chinese Academy of Medical Sciences Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Chinese Academy of Medical Sciences Diarrhea Vaccine Product Portfolios and Specifications
Table 115. Chinese Academy of Medical Sciences Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 116. Chinese Academy of Medical Sciences Main Business
Table 117. Chinese Academy of Medical Sciences Latest Developments
Table 118. Sinovac Biotech Ltd Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinovac Biotech Ltd Diarrhea Vaccine Product Portfolios and Specifications
Table 120. Sinovac Biotech Ltd Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 121. Sinovac Biotech Ltd Main Business
Table 122. Sinovac Biotech Ltd Latest Developments
Table 123. China National Biotec Corporation Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. China National Biotec Corporation Diarrhea Vaccine Product Portfolios and Specifications
Table 125. China National Biotec Corporation Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 126. China National Biotec Corporation Main Business
Table 127. China National Biotec Corporation Latest Developments
Table 128. Shanghai United Cell Biotechnology Basic Information, Diarrhea Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai United Cell Biotechnology Diarrhea Vaccine Product Portfolios and Specifications
Table 130. Shanghai United Cell Biotechnology Diarrhea Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 131. Shanghai United Cell Biotechnology Main Business
Table 132. Shanghai United Cell Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Diarrhea Vaccine
Figure 2. Diarrhea Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diarrhea Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Diarrhea Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Diarrhea Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Diarrhea Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Diarrhea Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Rotavirus Vaccine
Figure 12. Product Picture of Cholera Vaccine
Figure 13. Product Picture of EV71 Vaccine
Figure 14. Global Diarrhea Vaccine Sales Market Share by Type in 2026
Figure 15. Global Diarrhea Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Diarrhea Vaccine Consumed in Newborn
Figure 17. Global Diarrhea Vaccine Market: Newborn (2021-2026) & (K Dose)
Figure 18. Diarrhea Vaccine Consumed in Adult
Figure 19. Global Diarrhea Vaccine Market: Adult (2021-2026) & (K Dose)
Figure 20. Global Diarrhea Vaccine Sale Market Share by Application (2025)
Figure 21. Global Diarrhea Vaccine Revenue Market Share by Application in 2025
Figure 22. Diarrhea Vaccine Sales by Company in 2025 (K Dose)
Figure 23. Global Diarrhea Vaccine Sales Market Share by Company in 2025
Figure 24. Diarrhea Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Diarrhea Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Diarrhea Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Diarrhea Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 29. Americas Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 30. APAC Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 31. APAC Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 32. Europe Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 33. Europe Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 35. Middle East & Africa Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Americas Diarrhea Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Diarrhea Vaccine Revenue Market Share by Country (2021-2026)
Figure 38. Americas Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 39. Americas Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 40. United States Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Diarrhea Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Diarrhea Vaccine Revenue Market Share by Region (2021-2026)
Figure 46. APAC Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 47. APAC Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 48. China Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. India Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Diarrhea Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Diarrhea Vaccine Revenue Market Share by Country (2021-2026)
Figure 57. Europe Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 58. Europe Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 59. Germany Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. France Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Diarrhea Vaccine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 67. Egypt Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Diarrhea Vaccine in 2026
Figure 73. Manufacturing Process Analysis of Diarrhea Vaccine
Figure 74. Industry Chain Structure of Diarrhea Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Diarrhea Vaccine Sales Market Forecast by Region (2027-2032)
Figure 77. Global Diarrhea Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Diarrhea Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Diarrhea Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Diarrhea Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Diarrhea Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Diarrhea Vaccine
Figure 2. Diarrhea Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diarrhea Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Diarrhea Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Diarrhea Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Diarrhea Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Diarrhea Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Rotavirus Vaccine
Figure 12. Product Picture of Cholera Vaccine
Figure 13. Product Picture of EV71 Vaccine
Figure 14. Global Diarrhea Vaccine Sales Market Share by Type in 2026
Figure 15. Global Diarrhea Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Diarrhea Vaccine Consumed in Newborn
Figure 17. Global Diarrhea Vaccine Market: Newborn (2021-2026) & (K Dose)
Figure 18. Diarrhea Vaccine Consumed in Adult
Figure 19. Global Diarrhea Vaccine Market: Adult (2021-2026) & (K Dose)
Figure 20. Global Diarrhea Vaccine Sale Market Share by Application (2025)
Figure 21. Global Diarrhea Vaccine Revenue Market Share by Application in 2025
Figure 22. Diarrhea Vaccine Sales by Company in 2025 (K Dose)
Figure 23. Global Diarrhea Vaccine Sales Market Share by Company in 2025
Figure 24. Diarrhea Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Diarrhea Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Diarrhea Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Diarrhea Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 29. Americas Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 30. APAC Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 31. APAC Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 32. Europe Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 33. Europe Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Diarrhea Vaccine Sales 2021-2026 (K Dose)
Figure 35. Middle East & Africa Diarrhea Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Americas Diarrhea Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Diarrhea Vaccine Revenue Market Share by Country (2021-2026)
Figure 38. Americas Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 39. Americas Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 40. United States Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Diarrhea Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Diarrhea Vaccine Revenue Market Share by Region (2021-2026)
Figure 46. APAC Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 47. APAC Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 48. China Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. India Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Diarrhea Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Diarrhea Vaccine Revenue Market Share by Country (2021-2026)
Figure 57. Europe Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 58. Europe Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 59. Germany Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. France Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Diarrhea Vaccine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Diarrhea Vaccine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Diarrhea Vaccine Sales Market Share by Application (2021-2026)
Figure 67. Egypt Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Diarrhea Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Diarrhea Vaccine in 2026
Figure 73. Manufacturing Process Analysis of Diarrhea Vaccine
Figure 74. Industry Chain Structure of Diarrhea Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Diarrhea Vaccine Sales Market Forecast by Region (2027-2032)
Figure 77. Global Diarrhea Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Diarrhea Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Diarrhea Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Diarrhea Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Diarrhea Vaccine Revenue Market Share Forecast by Application (2027-2032)
